Literature DB >> 23729668

Circadian regulation of intestinal lipid absorption by apolipoprotein AIV involves forkhead transcription factors A2 and O1 and microsomal triglyceride transfer protein.

Xiaoyue Pan1, Mohamed Khalid Munshi, Jahangir Iqbal, Joyce Queiroz, Alaa Ahmed Sirwi, Shrenik Shah, Abdullah Younus, M Mahmood Hussain.   

Abstract

We have shown previously that Clock, microsomal triglyceride transfer protein (MTP), and nocturnin are involved in the circadian regulation of intestinal lipid absorption. Here, we clarified the role of apolipoprotein AIV (apoAIV) in the diurnal regulation of plasma lipids and intestinal lipid absorption in mice. Plasma triglyceride in apoAIV(-/-) mice showed diurnal variations similar to apoAIV(+/+) mice; however, the increases in plasma triglyceride at night were significantly lower in these mice. ApoAIV(-/-) mice absorbed fewer lipids at night and showed blunted response to daytime feeding. To explain reasons for these lower responses, we measured MTP expression; intestinal MTP was low at night, and its induction after food entrainment was less in apoAIV(-/-) mice. Conversely, apoAIV overexpression increased MTP mRNA in hepatoma cells, indicating transcriptional regulation. Mechanistic studies revealed that sequences between -204/-775 bp in the MTP promoter respond to apoAIV and that apoAIV enhances expression of FoxA2 and FoxO1 transcription factors and their binding to the identified cis elements in the MTP promoter at night. Knockdown of FoxA2 and FoxO1 abolished apoAIV-mediated MTP induction. Similarly, knockdown of apoAIV in differentiated Caco-2 cells reduced MTP, FoxA2, and FoxO1 mRNA levels, cellular MTP activity, and media apoB. Moreover, FoxA2 and FoxO1 expression showed diurnal variations, and their expression was significantly lower in apoAIV(-/-) mice. These data indicate that apoAIV modulates diurnal changes in lipid absorption by regulating forkhead transcription factors and MTP and that inhibition of apoAIV expression might reduce plasma lipids.

Entities:  

Keywords:  Apolipoproteins; Intestine; Lipid Absorption; Transcription Factors; Triglyceride

Mesh:

Substances:

Year:  2013        PMID: 23729668      PMCID: PMC3711312          DOI: 10.1074/jbc.M113.473454

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.

Authors:  R D Cohen; L W Castellani; J H Qiao; B J Van Lenten; A J Lusis; K Reue
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

2.  Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion.

Authors:  Fei Wang; Alison B Kohan; Tammy L Kindel; Kathryn L Corbin; Craig S Nunemaker; Silvana Obici; Stephen C Woods; W Sean Davidson; Patrick Tso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

3.  Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size.

Authors:  Song Lu; Ying Yao; Xiangying Cheng; Sonya Mitchell; Shuangying Leng; Songmei Meng; James W Gallagher; Gregory S Shelness; Gabriel S Morris; James Mahan; Sharon Frase; Charles M Mansbach; Richard B Weinberg; Dennis D Black
Journal:  J Biol Chem       Date:  2005-12-07       Impact factor: 5.157

4.  Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein.

Authors:  Paul Rava; Humra Athar; Caroline Johnson; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2005-05-16       Impact factor: 5.922

5.  Human intestinal lipoproteins. Studies in chyluric subjects.

Authors:  P H Green; R M Glickman; C D Saudek; C B Blum; A R Tall
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

Review 6.  Gastrointestinal satiety signals IV. Apolipoprotein A-IV.

Authors:  Patrick Tso; William Sun; Min Liu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-06       Impact factor: 4.052

7.  Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.

Authors:  N Duverger; G Tremp; J M Caillaud; F Emmanuel; G Castro; J C Fruchart; A Steinmetz; P Denèfle
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

8.  Hepatocyte nuclear factor-4 mediates apolipoprotein A-IV transcriptional regulation by fatty acid in newborn swine enterocytes.

Authors:  Shuangying Leng; Song Lu; Ying Yao; Zhisheng Kan; Gabriel S Morris; Brad R Stair; Mathew A Cherny; Dennis D Black
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-06-07       Impact factor: 4.052

9.  Characterization of recombinant human apoB-48-containing lipoproteins in rat hepatoma McA-RH7777 cells transfected with apoB-48 cDNA. Overexpression of apoB-48 decreases synthesis of endogenous apoB-100.

Authors:  M M Hussain; Y Zhao; R K Kancha; B D Blackhart; Z Yao
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

Review 10.  Circadian integration of metabolism and energetics.

Authors:  Joseph Bass; Joseph S Takahashi
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

View more
  13 in total

1.  Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.

Authors:  Xiaoming Li; Min Xu; Fei Wang; Alison B Kohan; Michael K Haas; Qing Yang; Danwen Lou; Silvana Obici; W Sean Davidson; Patrick Tso
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 2.  Circadian rhythms: a regulator of gastrointestinal health and dysfunction.

Authors:  Robin M Voigt; Christopher B Forsyth; Ali Keshavarzian
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-03-25       Impact factor: 3.869

3.  Bmal1 regulates production of larger lipoproteins by modulating cAMP-responsive element-binding protein H and apolipoprotein AIV.

Authors:  Xiaoyue Pan; M Mahmood Hussain
Journal:  Hepatology       Date:  2021-12-13       Impact factor: 17.298

Review 4.  Circadian regulators of intestinal lipid absorption.

Authors:  M Mahmood Hussain; Xiaoyue Pan
Journal:  J Lipid Res       Date:  2014-07-23       Impact factor: 5.922

5.  Nonalcoholic fatty liver disease in CLOCK mutant mice.

Authors:  Xiaoyue Pan; Joyce Queiroz; M Mahmood Hussain
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

6.  Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Kyu Yeon Hur; Ann-Hwee Lee
Journal:  J Lipid Res       Date:  2014-03-05       Impact factor: 5.922

7.  Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver.

Authors:  Xiaoyue Pan; Gary J Schwartz; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2018-10-28       Impact factor: 5.922

8.  Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis.

Authors:  Oh-oka Kyoko; Hiroshi Kono; Kayoko Ishimaru; Kunio Miyake; Takeo Kubota; Hideoki Ogawa; Ko Okumura; Shigenobu Shibata; Atsuhito Nakao
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

9.  Global and hepatocyte-specific ablation of Bmal1 induces hyperlipidaemia and enhances atherosclerosis.

Authors:  Xiaoyue Pan; Christopher A Bradfield; M Mahmood Hussain
Journal:  Nat Commun       Date:  2016-10-10       Impact factor: 14.919

Review 10.  CREBH Regulates Systemic Glucose and Lipid Metabolism.

Authors:  Yoshimi Nakagawa; Hitoshi Shimano
Journal:  Int J Mol Sci       Date:  2018-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.